Skip to main content

Advertisement

Log in

Effects of Humoral Immunity and Calreticulin Overexpression on Postoperative Course in Breast Cancer

  • Brief Communication
  • Published:
Pathology & Oncology Research

Abstract

The aim was to investigate whether the humoral immunity and overexpression of calreticulin in tumor tissue determined before surgery, correlate with incidence of metastases in breast cancer patients within two years after operation. Before operation, their humoral immunity and overexpression of caleticulin and Her-2/neu in tumor tissue were analyzed by immunohystochemistry. In 23 patients with metastases in regionally lymph nodes, seven had Her-2/neu overexpression. Among those seven patients, three developed distant metastasis (two women one year and in one woman two years after surgery) and all of them showed the presence of stromal IgG immunoreactivity and overexpression of calreticulin in their tumors tissue. Preliminary data showed that serum IgG immunoreactivity to tumor stroma in combination with overexpression of calreticulin in tumor cells correlate with postoperative appearance of metastases, particularly in the group of patients with Her-2/neu overexpressed tumors and metastases in axillary lymph nodes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO 2001 Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun 1:4

    PubMed  CAS  Google Scholar 

  2. Hayashi E, Kuramitsu Y, Okada F, Fujimoto M, Zhang X, Kobayashi M, Iizuka N, Ueyama Y, Nakamura K 2005 Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines. Proteomics 5(4):1024–1032

    Article  PubMed  CAS  Google Scholar 

  3. Dissemond J, Busch M, Kothen T, Mors J, Weimann TK, Lindeke A, Goos M, Wagner SN 2004 Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma. Cancer Lett 203(2):225–231

    Article  PubMed  CAS  Google Scholar 

  4. Sipione S, Ewen C, Shostak I, Michalak M, Bleackley RC 2005 Impaired cytolytic activity in calreticulin-deficient CTLs. J Immunol 174(6):3212–3219

    PubMed  CAS  Google Scholar 

  5. Fraser SA, Karimi R, Michalak M, Hudig D 2000 Perforin lytic activity is controlled by calreticulin. J Immunol 164(8):4150–4155

    PubMed  CAS  Google Scholar 

  6. Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G 2005 Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23(7):1379–1389

    Article  PubMed  Google Scholar 

  7. Ross JS, Fletcher JA 1998 The HER-2/neu Oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy. Oncologist 3(4):237–252

    PubMed  Google Scholar 

  8. Barbera-Guillem E, Nyhus JK, Wolford CC, Friece CR, Sampsel JW 2002 Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis and IgG immune complexes potentate the process. Cancer Res 62:7042–7049

    PubMed  CAS  Google Scholar 

  9. Shushakova N, Eden G, Dangers M, Zwirner J, Menne J, Gueler F, Luft FC, Haller H, Dumler I 2005 The urokinase/urokinase receptor system mediates the IgG immune complex-induced inflammation in lung. J Immunol 175(6):4060–4068

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aleksandra Erić.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erić, A., Juranić, Z., Milovanović, Z. et al. Effects of Humoral Immunity and Calreticulin Overexpression on Postoperative Course in Breast Cancer. Pathol. Oncol. Res. 15, 89–90 (2009). https://doi.org/10.1007/s12253-008-9112-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-008-9112-2

Keywords

Navigation